NCT00679679 Metformin and Lifestyle Intervention in Women With Polycystic Ovary Syndrome Status COMPLETED Phase PHASE4
NCT00678080 Metformin Versus Insulin in Pregnant Women With Type 2 Diabetes Status COMPLETED Phase NA
NCT00676338 Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4) Status COMPLETED Phase PHASE3
NCT00673465 Effect of SCH 497079 on Metabolic Parameters and Influence of Race/Ethnic Origin on Therapeutic Response (Study P05338)(COMPLETED) Status COMPLETED Phase PHASE1
NCT00672386 A Study of the Safety and Effectiveness of a R256918 in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT00670800 Study of Brain Function in Women With Insulin Resistant Polycystic Ovary Syndrome Status COMPLETED Phase NA
NCT00669864 Effect of Biphasic Insulin Aspart 30 Combined With Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin Status COMPLETED Phase PHASE4
NCT00667498 Metabolic Effect of Metformin in Obese Insulin Resistant Adolescents With Normal Glucose Tolerance Status COMPLETED Phase PHASE4
NCT00661362 Evaluate Efficacy and Safety of Saxagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00647023 Incretin Secretion in Women With Polycystic Ovary Syndrome (PCOS) Status TERMINATED Phase NA
NCT00631488 A Study to Test the Effectiveness and Safety of MK0893 in Combination With Other Drugs Used to Treat Type 2 Diabetes (0893-015) Status COMPLETED Phase PHASE2
NCT00627445 Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00624364 Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT00619697 Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT00617240 Strategies to Reduce Antipsychotic-Associated Weight Gain in Youth Status COMPLETED Phase PHASE2
NCT00617058 Improving Metabolic Parameters of Antipsychotic Child Treatment With Ziprasidone, Aripiprazole, and Clozapine Status TERMINATED Phase PHASE2